P- 30 CLINICAL FEATURES, TREATMENT, AND SURVIVAL OF PATIENTS WITH BUDD-CHIARI SYNDROME IN A HEPATOLOGY COLOMBIAN CENTER

Abstract

Introduction and Objectives: Budd-Chiari syndrome is defined as the obstruction of the hepatic venous flow. In Colombia, there is limited evidence regarding the characterization of these patients. This study aims to describe the clinical features, management, and survival of these patients in a Colombian hepatology reference center. This study aimed to describe the clinical features, management, and survival of patients diagnosed with Budd-Chiari Syndrome at a Colombian Hospital from 2010 to 2021. Materials and Methods: A retrospective descriptive longitudinal study of a cohort of patients with Budd-Chiari syndrome. Adult patients diagnosed with Budd-Chiari Syndrome were included. A descriptive analysis of the data was carried out. Results: A total of 31 patients diagnosed with Budd-Chiari syndrome were included. 58.1% (n=18) were women. The median age was 27 years [interquartile range (IQR) 23-27]. Ascites was the main clinical manifestation (87.1%, n=27). At the time diagnosis was made, 48.4% (n=15) were cirrhotic. Acquired thrombophilia was the main prothrombotic risk factor (48.4%, n=15), with the antiphospholipid syndrome as the most frequent cause (73.3%). The principal location of the outflow obstruction was in the hepatic veins (73.3%, n=22). 48.3% (n=14) had a Class II Rotterdam score (intermediate prognosis). 80.6% (n=25) were on anticoagulation. A transjugular intrahepatic portosystemic shunt (TIPS) was placed in 6 patients (19.4%), and five patients received liver transplants (16.1%). 25.8% (n=8) died. The median time from diagnosis to death was 337.1 days [interquartile range (IQR) 46.5-647.5]. Conclusions: Budd-Chiari syndrome is an infrequent disease poorly described in Colombia. This study shows that this population has similar risk factors, clinical features, and mortality as it is described in other cohorts.